REQUEST A DEMO
Total
USD $0.00
Search more companies

SinoMab BioScience Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: SinoMab BioScience Limited Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

SinoMab BioScience Limited is a biopharmaceutical company specializing in the research, development, manufacture and commercialization of immunological diseases. The company mainly develops biopharmaceuticals based on monoclonal antibodies. The company was founded in 2001 and is headquartered in Hong Kong.

Headquarters
Units 303 And 305 To 307, No. 15 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok
Hong Kong; Hong Kong;

Contact Details: Purchase the SinoMab BioScience Limited report to view the information.

Website: http://www.sinomab.com

Basic Information
Total Employees:
Purchase the SinoMab BioScience Limited report to view the information.
Outstanding Shares:
Purchase the SinoMab BioScience Limited report to view the information.
Financial Auditors:
Purchase the SinoMab BioScience Limited report to view the information.
Incorporation Date:
2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
28.39%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Ingenious Sino Limited (United Kingdom)
100%
Medinexus Pharma (Shanghai) Limited (China)
100%
Medinexus Pharma (Suzhou) Limited (China)
100%
Company Performance
Financial values in the chart are available after SinoMab BioScience Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
48.42%
Total operating revenue
-25.53%
Operating profit (EBIT)
23.87%
Net Profit (Loss) for the Period
32.42%
Total assets
-7.23%
Total equity
-31.81%
Operating Profit Margin (ROS)
3957.94%
Net Profit Margin
5350.93%
Return on Equity (ROE)
0.3%
Debt to Equity Ratio
74.41%
Quick Ratio
-0.65%
Cash Ratio
-0.88%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?